Starting on:
May 8, 2024
Ending on:
May 8, 2024
Moderator(s):
Max Credits:
3 Points
Provider:
FOUNTAIN HEALTHCARE
Claim Points
May 8, 2024
Ending on:
May 8, 2024
Moderator(s):
Dr.
BEATRICE JEPNGETICH
Clinical Hematologist MTRH Principal Investigator AMPATH Multiple myeloma Program
Venue: Clinical Hematologist MTRH Principal Investigator AMPATH Multiple myeloma Program
Max Credits:
3 Points
Provider:
FOUNTAIN HEALTHCARE
Claim Points
MULTIPLE MYELOMA TREATMENT TRAJECTORY
Starting on:
May 8, 2024
May 8, 2024
Ending on:
May 8, 2024
May 8, 2024
Venue:
Description
MULTIPLE MYELOMA TREATMENT TRAJECTORY
Objectives
To discuss the bispecific agents in multiple myeloma
To establish the availability of therapeutic options for patients with refractory or relapsed multiple myeloma
Presenters
-
Dr.
ATTAYA SUVANNASANKHA
Associate Professor of Clinical Medicine Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine Co-Leader of Multiple Myeloma Program Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indiana University, Indianapolis, USA